Red X iconGreen tick iconYellow tick icon
Skip to main content

Contact Details

Email
james.fingleton@otago.ac.nz

University Links

Position
Year 5 - Respiratory and Sleep Sub-Convener; Associate Professor
Department
Department of Medicine (Wellington)
Qualifications
BM, MRCP, PhD, CCST(Resp), FRACP, FThorSoc
Research summary
Associate Professor Fingleton is an academic respiratory physician with a specialist interest in asthma and COPD.
Teaching

Respiratory and Sleep Sub-Convener Year 5 MB ChB programme.

James enjoys teaching and mentoring and is always interested to hear from potential postgraduate candidates.

Memberships
  • Co-Chair New Zealand Asthma Network
  • Scientific Advisory Board member, Asthma and Respiratory Foundation New Zealand
  • Fellow of the Thoracic Society of Australia and New Zealand
  • Fellow of the Royal Australasian College of Physicians
Clinical
James is a respiratory physician and leads the severe and complex asthma service at Capital, Coast and Hutt Valley District.

Research

James is a clinician and researcher with a focus on collaborative approaches to improve care for patients living with lung diseases; through local service redesign, national guidelines, education and international research collaborations.

Research interests include:

  • Founding co-chief investigator of the Australia New Zealand Respiratory Audit Program (ANZRAP), a long-term research and quality improvement program to improve the quality of care, clinical outcomes and health service provision for people with respiratory illness in Australia and New Zealand.
  • Treatable traits: Following on from a PhD on phenotypes of airway disease James has an interest in the role of personalised medicine and applying the concept of treatable traits to optimise the management patients with asthma and COPD. He was the PI for a recently completed HRC funded feasibility study of “Treatable Traits for the Management of Asthma” and an Associate Investigator for the Centre of Excellence Treatable Traits, a consortium of world-renowned clinicians, researchers and key respiratory organisations who are collaborating to improve healthcare outcomes for people with chronic airway diseases.
  • Severe and complex asthma: James is co-chair of the national severe asthma MDM and has actrive research interests in severe and complex asthma.

Publications

Jenkins, C. R., Martin, A., Chang, C. L., Beasley, R., Wrobel, J. P., McDonald, V. M., … Hancox, R. J., on behalf of the PACE Investigators, including Dummer, J., Brockway, B., Fingleton, J., & Beckert, L. (2026). Bisoprolol to prevent adverse cardiac events (PACE) in COPD: A multicentre, double-blind, randomised, controlled, phase 3 trial. Lancet Respiratory Medicine, 14(3), 203-214. doi: 10.1016/s2213-2600(25)00390-x Journal - Research Article

Hancox, R. J., Jones, S. L., Baggott, C., Candy, S., Corna, N., Davies, C., Fingleton, J., … Rhodes, S., … Young, R. (2025). New Zealand Chronic Obstructive Pulmonary Disease Guidelines: 2025 update. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1625), 59-63. doi: 10.26635/6965.7149 Journal - Research Other

Lo, D., Wong, J., Keenan, R., Fingleton, J., & Wong, A. N. M. (2025). General practitioners’ attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer. Journal of Liquid Biopsy, 10, 100330. doi: 10.1016/j.jlb.2025.100330 Journal - Research Article

Hancox, R. J., Beasley, R., Beckert, L., Chan, A., Corna, N., Fingleton, J., … Manderson, Z., … Turner, J. (2025). Review of the New Zealand Asthma and Respiratory Foundation’s New Zealand Adolescent and Adult Asthma guidelines. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1617), 85-99. doi: 10.26635/6965.7061 Journal - Research Other

Fingleton, J., McLachlan, R., Sparks, J., Beasley, R., Agusti, A., Gibson, P. G., … Weatherall, M., … the Treatable Traits Study Group. (2025). Treatable trait guided asthma management: A feasibility study. Respirology, 30(6), 480-492. doi: 10.1111/resp.70016 Journal - Research Article

Back to top